Uncategorised - European Medical Journal

MASLD Trial Finds Similar Liver Fat Reductions - EMJ

Lifestyle Advice and Coaching Linked to Reduced Liver Fat in MASLD

A MASLD trial found liver fat reductions with initial advice, coaching and app support, without significant group differences.

Generic image of stock market gragh showing upwards trend in value

Iambic targets $806m valuation in US stock market debut

Nvidia-backed Iambic seeks up to $159.4m in a US IPO as it develops experimental cancer treatments using AI.

Management of EGFR-Mutated Metastatic NSCLC

As the treatment landscape for epidermal growth factor receptor-mutated metastatic non-small cell lung cancer grows, clinical…

surgeons removing brain tumor through surgery

Fractionated Stereotactic Radiosurgery Extends Brain Cancer Survival

Fractionated stereotactic radiosurgery prolongs survival and enhances local control in patients with resected brain tumor cavities.

Earlier Alzheimer’s Treatment May Offer Greater Value

Earlier Alzheimer’s Treatment Could Increase Lifetime Benefits

Modelling suggests earlier donanemab treatment could increase lifetime benefits for patients and society.

brain chip

Brain-Computer Interface Enables Coordinated Speech and Movement

Advanced brain-computer interface systems enable adults with paralysis to produce simultaneous speech and expressive body gestures.

Automated Segmentation for Fast TKV Quantification -EMJ

Automated Segmentation Method Enables Fast TKV Quantification

Automated segmentation method measured total kidney volume from unenhanced CT scans in seconds.

People standing in a circle looking at their phones together

MHRA backs ASA ban on oral weight-loss medicine adverts

The UK’s MHRA welcomes the ASA’s first bans on oral weight-loss medicine adverts and warns advertisers over rule breaches.

The latest edition of EMJ Cardiology

The latest edition of EMJ Cardiology is out now, featuring coverage from the European Society of Cardiology (ESC) Congress 2026.

Type 2 Diabetes Linked to Slower Braking in Older Drivers

Older drivers with Type 2 diabetes had slower simulator braking responses, with or without peripheral neuropathy.